Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
The answer will be option 3.
Nah, that is commercially sensitive to BH, he won't give that detail.
I think the price now is largely irrelevant. When the regulatory clearances are in place in China, Mexico, Bangladesh, India, and others, the orders should flow, smoothly.
Does anybody else read the box as SpeedLove
https://m.blog.naver.com/PostView.naver?blogId=ssohealthy&logNo=222720516889&targetKeyword=&targetRecommendationCode=1
I think there is no doubt that FF is part of BH growth strategy, one of their big and scientifically strong product releases. What we are not sure of is whether PXS have negotiated a good deal where they make good margins. BH have taken a lot of risk, spent a lot of money and effort, so I assume they got a deal that works very well for them.
Something + is brewing; The heightened tensions between the US, China and Russia are likely because they are in a bidding war for Provexis :)
Something + is brewing; The run on US banks is probably because all the investors are withdrawing their money to buy Provexis shares :)
Will we soon be getting an RNS to say that Gix now owns over 5% of the company?
Another version of the article, slightly different
https://m-tech-china-com.translate.goog/redian/2023/0313/032023_1237933.html?_x_tr_sl=pt&_x_tr_tl=fr&_x_tr_hl=en&_x_tr_pto=wapp
"Through random, double-blind and cross-design clinical research methods , the positive impact of lin trine on the platelet function of middle-aged and elderly Chinese people has been confirmed. Under the intervention of light lantin, the platelet function of middle-aged and elderly Chinese peo ple can be significantly improved. "
It's all extremely positive progress.
"Since the beginning of this year, under the support of Tomson By-Health Nutrition and Health Research Fund , two clinical studies of qingluosu on middle-aged and elderly Chinese have made gratifying progress. Positive effects on platelet function in elderly Chinese. With the intervention of Xeroxin, the platelet function of middle-aged and elderly people can be significantly improved. Coupled with the natural and safe source of Xeroxin, it has a significant competitive advantage in protecting the blood flow health of middle-aged and elderly Chinese."
https://www.healthista.com/5-ways-to-boost-healthy-blood-circulation/
I've emailed them to say that there is an ingredient listed that looks like it is not in the product and the website needs correcting.
Gix,
The product appears to have been around for several years. I can see vids on YouTube about it. As there is no mention of FF on the main website, bottle or box, it doesn't look like it has FF, although that other website very clearly says it has.
As it is a shampoo, it seems really unlikely.
If it has it, the only thing I can think is that it has been added recently and not yet added to the photos that show the ingredients list.
Everhopeful,
can you take us through an example scenario where another product comes along and makes FF redundant in a moment?
Would it be for gut health, hypertension, blood lipids, platelet aggregation, DVT, ruddy skin, reproductive health, reduction of exercise induced inflammation?
What would the existing customers do with their products, like Zaax, SOP Subarashi and VidaMaxx, would they just stop producing them?
Would By-health just stop with their submission to SAMR and not bother.
Would DSM not bother with marketing FF for gut-health?
Would Square Pharma cancel their ongoing trial?
Would those trying to get regulatory approval in Mexico, India and other countries just scrap their work to date?
Would like your insight.
Other things will come along. However, it would take them a long time to get to the same point as FF. FF is patented around the world and has cleared regulatory hurdles in many countries. Over $40m has been spent by companies researching into FF, which has provided an in-depth knowledge, which does not exist for other products.
I jus think that nobody is interested in this share apart from us. That will change when money starts coming in and China approvals are in place.
Hopalong,
That was my exact reason for me leaving this share years ago. Not sure how much he earns now, but I suspect it is probably multiples of what it was years ago when I felt he was milking the company for every penny. It was obvious that the shareholders meant nothing to him.
Thanks Gix.